Applied Microbiology International recognises Professor Obaro’s work translating childhood infectious disease research into vaccine development, surveillance and clinical guidance
Expert insights into sepsis collaboration, precision medicine, and host-response testing for acute infections
Applied Microbiology International recognizes the Monash University professor’s research into microbial solutions for climate change, ecosystem protection and One Health
Sepsis, superbugs and speed – inside the changing microbiology laboratory
Yale Professor Joe El-Khoury discusses Aletta, the ADOPT study, and how autonomous blood collection could improve standardization, capacity, and quality across laboratory medicine
Guest Editorial by Stephanie Ibbotson, Senior Director, Strategic Marketing and Market Access, Diasorin
As Gram-negative resistance becomes more complex, laboratories and clinicians are working together to turn susceptibility data into more targeted treatment decisions
Clinical microbiology experts Dr. Stella Antonara, OhioHealth, and Dr. J. Kristie Johnson, University of Maryland Medical Center, share their experiences in this SelectScience interview
Innovations aim to support earlier infectious disease detection through sensitive and efficient serology testing
bioMérieux to showcase integrated microbiology, molecular diagnostics, mass spectrometry, and laboratory informatics solutions
Understand the case for NHS pathology network transformation and the challenges facing UK labs
Screening tools are becoming vital in the fight against Candida auris, a rapidly spreading and deadly fungal infection with growing antifungal resistance
Automated blood culture system improves detection speed and supports earlier sepsis diagnosis
Top video insights on AMR, AST, and infectious disease diagnostics
One lab shares its experience switching to Streck’s quality control solution for molecular diagnostics testing
Dr. Barbara Jones, CEO of CLSI, discusses emerging resistance trends, the importance of updated breakpoints, and how CLSI continues to support laboratories navigating the evolving AMR landscape
Toni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research
SCCM 2026 presentation reports 19% reduction in sepsis mortality and double-digit operational improvements across four hospitals
The certification includes conformity assessment for near-patient testing, enabling its use outside traditional laboratories, directly at the point of care
Your trusted source for online, expert led clinical CE/CPD activities in 2026
Brilliance Candida 2 Agar and Spectra Candida Agar support earlier detection, faster outbreak response and more informed treatment decisions in healthcare settings*
iFAST ONE reduces antimicrobial susceptibility test time to under 3 hours
